Back

Precision medicine: myocardial fibrosis burden and genotype predict outcome in non-ischemic dilated cardiomyopathy (DCM)

31 August 2020 (08:30 - 08:30)
Organised by:
Congress Presentation Part of: Circulating and Imaging Biomarkers in Heart Failure Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2020

About the speaker

Photo
Associate Professor Elham Kayvanpour

University Hospital Heidelberg, Heidelberg (Germany)

6 More presentations in this session

Presentation thumbnail
Shear wave elastography by high frame rate echocardiography can detect diffuse myocardial fibrosis after heart transplantation
Doctor A. Popescu (Mainz, DE)
Abstract Slides
Presentation thumbnail
Leg raise can detect exercise-induced pulmonary arterial wedge pressure elevation
Doctor C. Nakata (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Global constructive work and left atrial reservoir function is reduced in patients with heart failure with preserved ejection fraction compared with patients with preclinical diastolic dysfunction.
Professor A. Chilingaryan (Yerevan, AM)
Abstract Slides
Presentation thumbnail
Atrial fibrillation and the prognostic performance of biomarkers in heart failure
Doctor E. Tan (Singapore, SG)
Abstract Slides
Presentation thumbnail
Prognostic implications of late gadolinium enhancement for re-worsening left ventricular ejection fraction in patients with dilated cardiomyopathy: a longitudinal study of left ventricular function.
Doctor T. Nabeta (Sagamihara, JP)
Abstract Slides

Access the full session

Session thumbnail
Circulating and Imaging Biomarkers in Heart Failure

The Event

Event poster

ESC Congress 2020

31 August 2020 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources